Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... based rescue medicine to be cleared ...

Inhaler colors often are used to identify specific types of inhalers (such as blue for rescue inhalers) that deliver medication ... diagnosed with chronic obstructive pulmonary disease (COPD) and ...

A first-in-class, pressurised metered-dose inhaler (pMDI), fixed-dose combination rescue medication containing ... chronic obstructive pulmonary disease (COPD) in the US, with the first patients ...

Results The study cohort included 20 388 propensity score matched pairs of new users initiating single inhaler triple therapy. Patients who received budesonide-glycopyrrolate-formoterol had a 9% ...

International Approvals, April 29, 2019 Alert EMA Panel Backs Triple Therapy Inhaler for COPD Temybric Ellipta combines fluticasone furoate, umeclidinium, and vilanterol in a single inhaler and is ...

Therefore, treating asthma is a matter of managing it to ward off symptoms and prevent exacerbations (asthma attacks), typically with inhaled medications called controller inhalers, and relieving ...

For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.